215 related articles for article (PubMed ID: 26765436)
1. Appraising MicroRNA-155 as a Noninvasive Diagnostic Biomarker for Cancer Detection: A Meta-Analysis.
Hou Y; Wang J; Wang X; Shi S; Wang W; Chen Z
Medicine (Baltimore); 2016 Jan; 95(2):e2450. PubMed ID: 26765436
[TBL] [Abstract][Full Text] [Related]
2. Potential role of microRNA-126 in the diagnosis of cancers: A systematic review and meta-analysis.
Yan J; Ma S; Zhang Y; Yin C; Zhou X; Zhang G
Medicine (Baltimore); 2016 Aug; 95(35):e4644. PubMed ID: 27583885
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-17 family as novel biomarkers for cancer diagnosis: a meta-analysis based on 19 articles.
Gu R; Huang S; Huang W; Li Y; Liu H; Yang L; Huang Z
Tumour Biol; 2016 May; 37(5):6403-11. PubMed ID: 26631037
[TBL] [Abstract][Full Text] [Related]
4. Plasma microRNA might as a potential biomarker for hepatocellular carcinoma and chronic liver disease screening.
Jiang L; Li X; Cheng Q; Zhang BH
Tumour Biol; 2015 Sep; 36(9):7167-74. PubMed ID: 25894380
[TBL] [Abstract][Full Text] [Related]
5. Serum microRNA-21 as a potential diagnostic biomarker for breast cancer: a systematic review and meta-analysis.
Li S; Yang X; Yang J; Zhen J; Zhang D
Clin Exp Med; 2016 Feb; 16(1):29-35. PubMed ID: 25516467
[TBL] [Abstract][Full Text] [Related]
6. Circulating microRNA-21 as a biomarker for the detection of various carcinomas: an updated meta-analysis based on 36 studies.
Wu K; Li L; Li S
Tumour Biol; 2015 Mar; 36(3):1973-81. PubMed ID: 25527152
[TBL] [Abstract][Full Text] [Related]
7. Identification and Evaluation of Serum MicroRNA-29 Family for Glioma Screening.
Wu J; Li L; Jiang C
Mol Neurobiol; 2015 Dec; 52(3):1540-1546. PubMed ID: 25367878
[TBL] [Abstract][Full Text] [Related]
8. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic value of miR-200 family in breast cancer: A meta-analysis and systematic review.
Thi Chung Duong T; Nguyen THN; Thi Ngoc Nguyen T; Huynh LH; Ngo HP; Thi Nguyen H
Cancer Epidemiol; 2022 Apr; 77():102097. PubMed ID: 35030348
[TBL] [Abstract][Full Text] [Related]
10. Clinical use of microRNAs as potential non-invasive biomarkers for detecting non-small cell lung cancer: a meta-analysis.
Wang H; Wu S; Zhao L; Zhao J; Liu J; Wang Z
Respirology; 2015 Jan; 20(1):56-65. PubMed ID: 25440223
[TBL] [Abstract][Full Text] [Related]
11. Increased circulating microRNA-155 as a potential biomarker for breast cancer screening: a meta-analysis.
Wang F; Hou J; Jin W; Li J; Yue Y; Jin H; Wang X
Molecules; 2014 May; 19(5):6282-93. PubMed ID: 24840899
[TBL] [Abstract][Full Text] [Related]
12. Serum miR-16 as a potential biomarker for human cancer diagnosis: results from a large-scale population.
Huang Z; Chen W; Du Y; Guo Q; Mao Y; Zhou X; Hua D
J Cancer Res Clin Oncol; 2019 Mar; 145(3):787-796. PubMed ID: 30706130
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic role of circulating MiR-21 in colorectal cancer: a update meta-analysis.
Liu T; Liu D; Guan S; Dong M
Ann Med; 2021 Dec; 53(1):87-102. PubMed ID: 33108223
[TBL] [Abstract][Full Text] [Related]
14. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study.
Lin XJ; Chong Y; Guo ZW; Xie C; Yang XJ; Zhang Q; Li SP; Xiong Y; Yuan Y; Min J; Jia WH; Jie Y; Chen MS; Chen MX; Fang JH; Zeng C; Zhang Y; Guo RP; Wu Y; Lin G; Zheng L; Zhuang SM
Lancet Oncol; 2015 Jul; 16(7):804-15. PubMed ID: 26088272
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-145 as ideal biomarker for the diagnosis of various carcinomas.
Hou Y; Wang X; Chen Y; Mu S
Tumour Biol; 2015 Apr; 36(4):2641-9. PubMed ID: 25476854
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis.
Wang Y; Gao X; Wei F; Zhang X; Yu J; Zhao H; Sun Q; Yan F; Yan C; Li H; Ren X
Gene; 2014 Jan; 533(1):389-97. PubMed ID: 24076132
[TBL] [Abstract][Full Text] [Related]
17. Serum microRNA signatures and metabolomics have high diagnostic value in colorectal cancer using two novel methods.
Liu HN; Liu TT; Wu H; Chen YJ; Tseng YJ; Yao C; Weng SQ; Dong L; Shen XZ
Cancer Sci; 2018 Apr; 109(4):1185-1194. PubMed ID: 29363233
[TBL] [Abstract][Full Text] [Related]
18. Discovery and function exploration of microRNA-155 as a molecular biomarker for early detection of breast cancer.
Liu X; Chang Q; Wang H; Qian H; Jiang Y
Breast Cancer; 2021 Jul; 28(4):806-821. PubMed ID: 33475963
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-150 as a Potential Biomarker in Diagnosis of Cancer: a Meta-Analysis.
Yan J; Li X; Peng L; Shen X; Dang Y; Zhang G
Clin Lab; 2017 Jul; 63(7):1187-1197. PubMed ID: 28792699
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA biomarkers in whole blood for detection of pancreatic cancer.
Schultz NA; Dehlendorff C; Jensen BV; Bjerregaard JK; Nielsen KR; Bojesen SE; Calatayud D; Nielsen SE; Yilmaz M; Holländer NH; Andersen KK; Johansen JS
JAMA; 2014 Jan 22-29; 311(4):392-404. PubMed ID: 24449318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
